Category: Cancer Treatment
Global Cancer Treatment
-
Global Frozen Tissues Samples Competitive Landscape Professional Research Report 2024
... This preservation method involves quickly freezing tissue samples, often using liquid nitrogen or other cryogenic agents, to halt biological processes and maintain the integrity of cellular structures. Researchers and clinicians use frozen tissue samples for ... Read More
-
Global Colorectal Cancer Molecular Diagnostics Competitive Landscape Professional Research Report 2024
... associated with colorectal cancer. These diagnostics focus on understanding the genetic and molecular characteristics of colorectal tumors, helping healthcare professionals make more accurate diagnoses and tailor personalized treatment plans for patients. The tests involve analyzing ... Read More
-
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Professional Research Report 2024
... cancer research and treatment. CTCs are rare cancer cells that have detached from a primary tumor and entered the bloodstream, enabling them to potentially spread to other parts of the body and form metastatic tumors. ... Read More
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
... is projected to grow from USD 59 million in 2024 to USD 2,347 million by 2029 at a CAGR of 108.9%. However, the candidates for exosome-based therapeutics are expected to be launched in the market ... Read More
-
2024 Global Molecular Diagnostics Market in the US, Europe, Japan - 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Pater
... Tests This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More
-
2024 World Molecular Diagnostics Market in 92 Countries: 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing ... Read More
-
Epidermal Growth Factors (EGFs) Market (Type of EGFs: TGF-alpha, Amphiregulin, Epiregulin, Betacellulin, and Others, and Application: Skincare Products, Wound Healing, cancer Therapy, Autoimmune Disorders, Regenerative Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Trends, and Forecast, 2024-2034 Epidermal Growth Factors (EGFs) Market – Scope of Report TMR’s report on the global epidermal growth factors (EGFs) market studies the past as well as the current growth trends and opportunities ... Read More
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Global Forecast to 2029
... & non-stem cell therapies market is projected to reach USD 22.2 billion by 2029 from USD 5.5 billion in 2024, at a CAGR of 32.3% during the forecast period. The growth of this market is ... Read More
-
Drug-Device Combination Products Market by Product (Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps), Application (Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder), End-user - Global Forecast 2024-2030
... 133.95 billion in 2023 and expected to reach USD 144.59 billion in 2024, at a CAGR 8.09% to reach USD 231.05 billion by 2030. A drug-device combination product is a unique class of healthcare products ... Read More
-
Artificial Intelligence in Medical Diagnostics Market by Component (Hardware, Services, Software), Technology (Computer Vision, Machine Learning Platforms, Natural Language Processing), Application, End-User - Global Forecast 2024-2030
... estimated at USD 1.00 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 17.23% to reach USD 3.04 billion by 2030. Artificial intelligence (AI) in the medical diagnostics market ... Read More
-
Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030
... USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030. The human microbiome is the collective genomes of the microorganisms ... Read More
-
Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 5.14 billion in 2024, at a CAGR 9.95% to reach USD 9.09 billion by 2030. Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat ... Read More
-
Cancer Biomarkers Market by Biomarker Type (Genetic, Protein), Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer), Technology, Application, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 31.23 billion in 2024, at a CAGR 10.71% to reach USD 57.75 billion by 2030. Cancer biomarkers are substances or processes that can be measured in parts of ... Read More
-
Rare Disease Genetic Testing Market by Disease Type (Cancer, Cardiovascular Disorders, Dermatology Diseases), Technology (Array Technology, FISH, Karyotyping), Specialty, End-User - Global Forecast 2024-2030
... 1.33 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 16.15% to reach USD 3.80 billion by 2030. Rare disease genetic testing refers to the process of analyzing DNA, ... Read More
-
Global anal fissure therapeutics market - 2024-2031
... period 2024-2031. An anorectal condition marked by inflammation or tearing of the lining of the lower rectum is known as an anal fissure. During bowel movements, it causes considerable discomfort and blood. The ailment is ... Read More
-
Familial Adenomatous Polyposis Treatment Market by Type (Aspirin, CEQ-508, Eflornithine Hydrochloride), End-Users (Clinics & Hospitals, Diagnostic Centres, Home Healthcare), Distribution Channel - Global Forecast 2024-2030
... USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.43% to reach USD 1.85 billion by 2030. Familial Adenomatous Polyposis (FAP) treatment refers to the medical interventions ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Next-Generation Cancer Diagnostics Market by Technology (Clustered Regularly Interspaced Short Palindromic Repeats Diagnostics, DNA Microarrays, Lab-on-a-Chip & Reverse Transcriptase-PCR), Cancer Type (Bladder Cancer, Breast Cancer, Cervical Cancer), Application, Function - Global Forecast 2024-2030
... Cancer Diagnostics Market size was estimated at USD 9.77 billion in 2023 and expected to reach USD 12.02 billion in 2024, at a CAGR 24.12% to reach USD 44.36 billion by 2030. The next-generation cancer ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Procarbazine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... of US$ 102.83 million by 2030 with a CAGR of 3.20% during the forecast period 2024-2030. North American market for Procarbazine was valued at $ 32.71 million in 2023 and will reach $ 40.48 million ... Read More
-
Global CAR T-Cell therapy Market Size study & Forecast, by Indication (Lymphoma, Acute Lymphocytic Leukemia, Others), By Drug Type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others), By End user (Hospitals, Cancer Treatment Centers), and Regional Analysis, 2023-2030
... 2023-2030 Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimeric ... Read More
-
Global Human Microbiome Market Report by Application (Therapeutics, Diagnostics) Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Other Diseases) Product (Probiotics, Prebiotics, Symboitics, Other Products), Countries and Company Analysis, 2024-2032
... Human Microbiome Market will grow US$ 3.05 Billion by 2032 from US$ 0.72 Billion in 2023, with a CAGR of 17.48% during 2023-2032. The human microbiome is a collection of microorganisms found on and within ... Read More
-
Cancer Biomarker Global Market Opportunities And Strategies To 2033
... Risk Assessment4) By Cancer Type: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach CancerCovering: Roche Diagnostics; Novartis AG; Illumina; Hologic Inc.; Thermo ... Read More
-
Tumor Ablation Market Size, Share & Trends by Technology (Radiofrequency, Microwave, Laser, IRE, HIFU, Cryoablation), Product (Generators, Probes), Mode (Surgical, Laparoscopic, Percutaneous), Cancer (Liver, Lung, Bone), End User (Hospitals, Clinic) & Region - Global Forecast to 2029
... to 2029 The global tumor ablation market is projected to reach USD 1.4 billion by 2029 from USD 0.8 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Aging population, coupled with ... Read More
-
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Non-Cancer Application, Sample Type, Region & Country Analysis), Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031
... 2031 The global liquid biopsy market is predicted to reach US$ 13.72 Billion by 2031, from US$ 3.94 Billion in 2023. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without ... Read More